High prophylactic LMWH dose successfully suppressed hemostatic activation in pregnant woman with a new prothrombin c.1787G>A mutation.

[1]  D. Radojkovic,et al.  Does Anticoagulant Therapy Improve Pregnancy Outcome Equally, Regardless of Specific Thrombophilia Type? , 2014, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[2]  T. Murate,et al.  Development of a new laboratory test to evaluate antithrombin resistance in plasma. , 2014, Thrombosis research.

[3]  D. Radojkovic,et al.  A novel prothrombin mutation in two families with prominent thrombophilia – the first cases of antithrombin resistance in a Caucasian population , 2013, Journal of thrombosis and haemostasis : JTH.

[4]  Y. Miyawaki.  Thrombosis from a prothrombin mutation conveying antithrombin resistance , 2013 .

[5]  A. Kaider,et al.  ProCGlobal and endogenous thrombin potential during pregnancy. , 2010, American journal of obstetrics and gynecology.

[6]  D. Radojkovic,et al.  Thrombophilia in Women with Pregnancy-Associated Complications: Fetal Loss and Pregnancy-Related Venous Thromboembolism , 2010, Gynecologic and Obstetric Investigation.

[7]  S. Eichinger,et al.  Prediction of recurrent venous thromboembolism by endogenous thrombin potential and D-dimer. , 2008, Clinical chemistry.

[8]  J. Kingdom,et al.  The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia , 2006, Thrombosis and Haemostasis.

[9]  P. Langhorne,et al.  Thrombophilia in pregnancy: a systematic review , 2006, British journal of haematology.

[10]  A. Kaider,et al.  Prospective evaluation of coagulation activation in pregnant women receiving low-molecular weight heparin , 2004, Thrombosis and Haemostasis.

[11]  R. Grossmann,et al.  The Impact of Dalteparin (Fragmin®) on Thrombin Generation in Pregnant Women with Venous Thromboembolism: Significance of the Factor V Leiden Mutation , 2001, Thrombosis and Haemostasis.

[12]  S. Spitzer,et al.  A prothrombin gene mutation is significantly associated with venous thrombosis. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[13]  P. Reitsma,et al.  A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. , 1996, Blood.